| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |